Status | Study |
Active, not recruiting |
Study Name: Study of of APL-2 Therapy in Patients Geographic Atrophy Condition: Geographic Atrophy Date: 2015-07-14 Interventions: Drug: APL-2 Other: Sham Procedure |
Recruiting |
Study Name: An Epidemiologic Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima A). Condition: Geographic Atrophy Date: 2015-06-19 Interventions: Other: No intervention No intervention administered in this study |
Recruiting |
Study Name: An Epidemiologic Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima B) Condition: Geographic Atrophy Date: 2015-03-23 Interventions: Other: No intervention No intervention administered in this study |
Completed |
Study Name: Geographic Atrophy and Intravitreal Ranibizumab Injections Condition: Age-related Macular Degeneration Geographic Atrophy Date: 2015-02-20 Interventions: Drug: Ranibizumab The medication Ranibizumab is routine standard of care for patients with wet AMD, and |
Active, not recruiting |
Study Name: A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy Condition: Geographic Atrophy Date: 2014-11-07 Interventions: Other: Sham Sham injection wil |
Recruiting |
Study Name: A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (SPECTRI) Condition: Geographic Atrophy Date: 2014-07-15 Interventions: Drug: Lampalizumab 10-mg dose |
Recruiting |
Study Name: A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA) Condition: Geographic Atrophy Date: 2014-07-15 Interventions: Drug: Lampalizumab 10-mg dose |
Terminated |
Study Name: Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration Condition: Age-Related Macular Degeneration Geographic Atrophy Date: 2014-05-12 Interventions: Biological: Human Central Nervous System Stem Cells Other Name: HuCNS-SC |
Completed |
Study Name: Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration Condition: Geographic Atrophy Age-Related Macular Degeneration Date: 2014-05-01 Interventions: Drug: Emixustat HCl Tablet Tab |
Completed |
Study Name: Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride Condition: Geographic Atrophy Date: 2013-02-28 Interventions: Drug: ACU-4429 Take orally onc |